| Přispěvatelé: |
Bellinato, Francesco, Gisondi, Paolo, Valerio Marzano, Angelo, Piaserico, Stefano, De Simone, Clara, Damiani, Giovanni, Argenziano, Giuseppe, Venturini, Marina, Dapavo, Paolo, Costanzo, Antonio, Megna, Matteo, Prignano, Francesca, Burlando, Martina, Satolli, Francesca, Carugno, Andrea, Pezzolo, Elena, Romanelli, Marco, Cuccia, Aldo, Girolomoni, Giampiero, Bellinato, F, Gisondi, P, Marzano, A, Piaserico, S, De Simone, C, Damiani, G, Argenziano, G, Venturini, M, Dapavo, P, Costanzo, A, Megna, M, Prignano, F, Burlando, M, Satolli, F, Carugno, A, Pezzolo, E, Romanelli, M, Cuccia, A, Girolomoni, G, Bellinato, F., Gisondi, P., Marzano, A. V., Piaserico, S., De Simone, C., Damiani, G., Argenziano, G., Venturini, M., Dapavo, P., Costanzo, A., Megna, M., Prignano, F., Burlando, M., Satolli, F., Carugno, A., Pezzolo, E., Romanelli, M., Cuccia, A., Girolomoni, G. |
| Popis: |
Background: Generalized pustular psoriasis (GPP) is a rare, severe inflammatory skin disease characterized by recurrent episodes of flares. Characteristics of patients experiencing a flare are hardly described in a real-life setting. The aim of the study is to investigate the clinical characteristics of patients experiencing a flare of GPP. Methods: Multicenter retrospective observational study on consecutive patients experiencing a flare of GPP between 2018 and 2022. Disease severity and quality of life were assessed by Generalized Pustular Psoriasis Area, Body Surface Area (BSA), and Severity Index (GPPASI), and Dermatology life quality index (DLQI) questionnaire, respectively. Visual analogue scale (VAS) of itch and pain, triggers, complications, comorbidities, pharmacological therapies, and outcome were collected. Results: A total of 66 patients, 45 (68.2%) females, mean age 58.1 ± 14.9 years, were included. The GPPASI, BSA, and DLQI were 22.9 ± 13.5 (mean ± standard deviation), 47.9 ± 29.1, and 21.0 ± 5.0, respectively. The VAS of itch and pain were 6.2 ± 3.3 and 6.2 ± 3.0, respectively. Fever (>38 °C) and leukocytosis (WBC > 12 × 109/L) were found in 26 (39.4%) and 39 (59.1%) patients, respectively. Precipitating triggers were identified in 24 (36.3%) and included infections (15.9%), drugs (10.6%), stressful life events (7.6%), and corticosteroids withdrawal (3.0%). Fourteen (21.2%) patients were hospitalized because of complications including infections in 9 (13.6%) leading to death in one case and hepatitis in 3 (4.5%). Conclusions: GPP flares can be severe and cause severe pain and itch with significant impact on the quality of life. In about one-third of patients the flare may have a persistent course and, with complications, lead to hospitalization. |
